Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 6, 1998, Pages 317-322

  Ishii, Kazunari ^a,c   Sasaki, Masahiro ^a   Yamaji, Shigeru ^a   Sakamoto, Setsu ^a,b   Kitagaki, Hajime ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

2 (18F) fluoro 2 deoxy D glucose; Alzheimer's disease; Cerebral glucose metabolism; Hippocampus; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; MALE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; ALZHEIMER DISEASE; FEMALE; GLUCOSE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031726767     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017083     Document Type: Article

References (35)

1. Hyman BT, Van Hoesen GW, Damasio AR: Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 1990; 40:1721-1730.
2. Arriagada P, Growdon JH, Hedley-Whyte ET, Hyman BT: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-639.
3. Kesslak JP, Nalcioglu O, Cotman CW: Quantification of magnetic resonance scans for hippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
4. Scheltens PH, Leys D, Barkhof F, et al: Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55: 967-972.
5. Jack CR, Petersen RC, O'Brien PC, Tangalos EG: MR-based hippocampal volumetry in the diangosis of Alzheimer's disease. Neurology 1992;42:183-188.
6. Watson C, Andermann F, Gloor P, et al: Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750.
7. de Leon MJ, Golomb J, George AE, et al: The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. AJNR 1993;14:897-906.
8. Kiliany RJ, Moss MB, Albert MS, Sandor T, Tieman J, Jolesz F: Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
9. Lehéricy S, Baulac M, Chiras J, et al: Amygdalohippocampal MR volume measurements in the early stages of Alzheimer's disease. AJNR 1994;15:927-937.
10. Ikeda M, Tanabe H, Nakagawa Y, et al: MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer's disease. Neuroradiology 1994;36:7-10.
11. Ishii K, Kitagaki H, Kono M, Mori E: Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by positron emission tomography. J Nucl Med 1996;37:1159-1165.
12. Cutler NR, Haxby JV, Duara R, et al: Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol 1985;18:298-309.
13. 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. J Neurol Neurosurg Psychiatry 1991;54:672-678.
14. Kumar A, Schapiro MB, Grady C, et al: High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991;4:35-46.
15. Jagust WJ, Eberling JL, Richardson BC, et al: The cortical topography of temporal lobe hypomelabolism in early Alzheimer's disease. Brain Res 1993;629:189-198.
16. Ohnishi T, Hoshi H, Nagamachi S, et al: High-resolution SPECT to assess hippocampal perfusion in neuropsychiatric diseases. J Nucl Med 1995;36:1163-1169.
17. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E: Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer's disease. J Nucl Med 1998;39:293-298.
18. 99mTc-ECD SPECT in patients with Alzheimer's disease (AD) in the early stage. Jpn J Nucl Med (Kakuigaku) 1996;33:1197-1206.
19. Folstein MF, Folstein SE, McHugh PR: 'MiniMental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Honma A, Fukuzawa K, Tsukada Y, Ishii T, Hasegawa K, Mohs RC: Development of a Japanese version of Alzheimer's Disease Assessment Scale (ADAS). Jpn J Geriatr Psychiatry 1992;3:647-655.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Taks Force on Alzheimer's Disease. Neurology 1984;34:939-944.
22. Ishii K, Sasaki M, Kitagaki H, Sakamoto S, Yamaji S, Maeda K: Regional difference of cerebral blood flow and oxidative metabolism in human cortex. J Nucl Med 1996;37:1086-1088.
23. Ishii K, Sasaki M, Kitagaki H, et al: Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 1997;38:925-928.
24. Iida H, Miura S, Kanno I, et al: Design of evaluation of Headtome IV: a whole body positron emission tomograph. IEEE Trans Nucl Sci 1989;NS-37:1006-1010.
25. Phelps ME, Huang SC, Huffman EJ, Selin C, Sokoloff L, Kuhl DE: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 1979; 6:371-388.
26. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RSJ: The relationship between global and local changes in PET scans. J Cereb Blood Row Metab 1990; 10:458-466.
27. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ: Plastic transformation of PET images. J Comp Assist Tomogr 1991;15:634-649.
28. Talairach J, Tournoux P: Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart, Thieme, 1988.
29. Friston KJ, Holmes AP, Worsely KJ, Poline JB, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Map 1995;2:189-210.
30. Duara R, Grady C, Haxby J, et al: Human brain glucose utilization and cognitive function in relation to age. Ann Neurol 1984;16:702-713.
31. Moeller JR, Ishikawa T, Dhawan V, et al: The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996;16:385-398.
32. Minoshima S, Giordani B, Barent S, Frey KA, Foster NL, Kuhl DE: Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
33. Minoshima S, Foster NL, Kuhl DE: Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895.
34. Minoshima S, Frey KA, Koeppe RA. Foster NL, Kuhl DE: A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238-1248.
35. Minoshima S, Koeppe RA, Frey KA, Kuhl DE: Anatomic standardization: Linear scaling and nonlinear warping of functional brain images. J Nucl Med 1994;35:1528-1537.